Publication | Closed Access

Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation

Regenerative MedicineMesenchymal Stem CellsMedicinePulse TreatmentBone MarrowStem-cell TherapyOsteoporosisBiomedical EngineeringStem CellsMesenchymal Stem CellOrthopaedic Surgery